A phase 2 double-blind, RandomizEd, prospective, placebo controlled STudy of NanO2 TM combined with Radiation and temozolomide in patients with newly-diagnosed glioblastoma multiformE: RESTORE
Clinical Trial Grant
Awarded By
NuvOx Pharma, LLC
Start Date
July 14, 2023
End Date
August 31, 2027
Awarded By
NuvOx Pharma, LLC
Start Date
July 14, 2023
End Date
August 31, 2027